Fermer le menu


As a commercial stage biotech company, Valneva’s mission is to help protect the lives of people around the world through the discovery, development and commercialization of innovative vaccines against infectious diseases. Our vision is to contribute to a world in which no one dies or suffers from a vaccine-preventable disease. Valneva aims to become the leading vaccine biotech company by complementing product sales growth with the development of high value R&D assets. More information is available at www.valneva.com.


Strategic application domain: Human Medicine

Application market: Infectious Diseases, Others

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Vaccine

Created on may 27th, 2013 - 400 employees



World Trade Center Lyon - Tour Oxygène, 10-12 boulevard Marius Vivier Merle 69003 LYON



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.